Watson and GeneraMedix announced that Nulecit, a generic of Ferrlecit (sodium ferric gluconate complex in sucrose injection; sanofi-aventis), has been approved for the treatment of iron deficiency ...

Watson Pharmaceuticals, Inc. announced that it is initiating launch activities of Nulecit (sodium ferric gluconate complex in sucrose injection), following FDA approval of GeneraMedix Inc.'s, ...

MORRISTOWN, N.J. — The Food and Drug Administration has approved a generic treatment for iron deficiency anemia made by Watson Pharmaceuticals, Watson said Thursday. The drug maker announced the ...